Prescribing medications for attention-deficit/hyperactivity disorder in children: a retrospective analysis of a Japanese health insurance claims database
CONCLUSIONS: In Japan, GXR has become an increasingly preferred medication for ADHD, particularly for female patients and children aged 6-12 years, with new prescriptions exceeding those of OROS-MPH since late…
Suggested reading